1. Optimal IFN therapy for 40-year-old patients with severe HCV-1b infection 
Hisashi Moriguchi, Makoto Kobayashi, Raymond T. Chung, Chifumi Sato 
Gastroenterology 
Volume 124, Issue 4, Pages (April 2003)
DOI: /gast
Copyright © 2003 American Gastroenterological Association Terms and Conditions

2. Fig. 1
Sensitivity analysis on SVR rate for the patient with HCV-1b (F3) and transition probability of liver diseases for NR patients. Two-way sensitivity analysis in the case of severe HCV-1b infection (HCV-1b[F3]) (40 years old). Strategy 5 is treat-all strategy (see Moriguchi et al. Hepatology 2002).
Gastroenterology  , DOI: ( /gast )
Copyright © 2003 American Gastroenterological Association Terms and Conditions